glp-1 obesity drugs pipeline A Beginner's Guide to Investing in Weight Loss Next Generation Obesity Drug Pipeline
Description
Diabetologia (2015)
CRH, Corticotropin-releasing hormone
Age can also play a role, as older adults may experience more pronounced digestive side effects
While most adults who have taken GLP-1 drugs say their insurance covered at least a part of the cost of these drugs, about a quarter (27%) of users with health insurance say they paid the full cost of the drugs themselves
A number of studies have shown that GLP-/GIPR dual agonists can achieve better blood glucose control, insulin sensitivity, lipid metabolism and weight loss compared with GLP-1 alone [136,137]
It is taken once daily and is being studied as a needle-free alternative to injectable GLP-1 treatments
